Back to search
Hematopoietic/Lymphoid Cancer
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hematopoietic/Lymphoid Cancer trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Hematopoietic/Lymphoid Cancer trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: Blood cancers (such as leukemias) can be hard to treat, especially if they have mutations in the TP53 or RAS genes. These mutations can cause the c…
This is a single-center, single-arm, observational clinical study evaluating the efficacy and safety of low-dose liposomal amphotericin B (50 mg/day, intravenou…
The study is designed to examine the feasibility and safety of collecting autologous hematopoietic stem cells (HSCs) to be combined with CAR T-cell therapy for…
This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information ga…
This study collects information about complications and clinical response in cancer patients treated with anti-VEGF-related therapies. This study aims to observ…
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing s…
This phase I trial evaluates the best dose and side effects of copper (64Cu)-DOTA-pembrolizumab positron emission tomography (PET) for the study of PD1 expressi…
This phase II trial studies fentanyl buccal tablet or morphine to see how well it works compared to a placebo in controlling shortness of breath during or after…